Table 2.

Incidence of relapse- and nonrelapse-related mortality across frail subgroups

Frail based on age (n = 13)Frail based on impairments (n = 32)Ultrafrail (n = 20)
Early mortality (<100 days), n (%) 1 (8) 4 (13) 5 (25) 
Relapse-related — — 
Nonrelapse-related 
Unknown — — 
Nonrelapse-related mortality, n (%) 1 (8) 7 (22) 6 (30) 
Relapse-related mortality, n (%) 4 (31) 10 (31) 4 (15) 
Cause of death 1 infection 1 infection
4 toxicity
1 other
1 unknown 
2 infection
3 other
1 unknown 
Frail based on age (n = 13)Frail based on impairments (n = 32)Ultrafrail (n = 20)
Early mortality (<100 days), n (%) 1 (8) 4 (13) 5 (25) 
Relapse-related — — 
Nonrelapse-related 
Unknown — — 
Nonrelapse-related mortality, n (%) 1 (8) 7 (22) 6 (30) 
Relapse-related mortality, n (%) 4 (31) 10 (31) 4 (15) 
Cause of death 1 infection 1 infection
4 toxicity
1 other
1 unknown 
2 infection
3 other
1 unknown 

Second primary malignancy.

One with heart failure, 1 with bleeding due to thrombocytopenia, and 1 with lymphoma.

or Create an Account

Close Modal
Close Modal